FDA
-
-
-
-
-
-
-
Orchestra BioMed receives $15 million from Ligand under financing agreement
-
-
-
-
-
-
-
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
-
-
-
-
-
-
-
Orchestra BioMed to Host Business Update Call on November 12, 2025
-
-
-
-
-
-
-
BTIG Downgrades Orchestra BioMed Inc. (OBIO) to Neutral
-
-
-
-
-
-
-
Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings
-
-
-
-
-
-
-
Vivasure Medical Submits PMA Application for PerQseal® Elite and Secures Expanded Venous Indication in Europe
-
-
-
-
-
-
-
Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
-
323,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

